Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I0W9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 227 | 231 | PF00656 | 0.521 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.699 |
CLV_PCSK_KEX2_1 | 52 | 54 | PF00082 | 0.598 |
CLV_PCSK_PC1ET2_1 | 52 | 54 | PF00082 | 0.598 |
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.474 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.459 |
DOC_MAPK_gen_1 | 4 | 12 | PF00069 | 0.480 |
DOC_MAPK_JIP1_4 | 19 | 25 | PF00069 | 0.564 |
DOC_MAPK_MEF2A_6 | 19 | 27 | PF00069 | 0.641 |
DOC_MAPK_MEF2A_6 | 205 | 212 | PF00069 | 0.497 |
DOC_PP1_RVXF_1 | 125 | 131 | PF00149 | 0.493 |
DOC_PP4_FxxP_1 | 232 | 235 | PF00568 | 0.515 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.612 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.637 |
DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.505 |
LIG_14-3-3_CanoR_1 | 190 | 195 | PF00244 | 0.518 |
LIG_14-3-3_CanoR_1 | 53 | 57 | PF00244 | 0.560 |
LIG_AP2alpha_1 | 228 | 232 | PF02296 | 0.552 |
LIG_BRCT_BRCA1_1 | 218 | 222 | PF00533 | 0.428 |
LIG_EH_1 | 74 | 78 | PF12763 | 0.587 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.495 |
LIG_FHA_1 | 136 | 142 | PF00498 | 0.348 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.559 |
LIG_FHA_2 | 222 | 228 | PF00498 | 0.381 |
LIG_FHA_2 | 52 | 58 | PF00498 | 0.497 |
LIG_GBD_Chelix_1 | 170 | 178 | PF00786 | 0.344 |
LIG_IRF3_LxIS_1 | 150 | 157 | PF10401 | 0.497 |
LIG_LIR_Apic_2 | 230 | 235 | PF02991 | 0.598 |
LIG_LIR_Gen_1 | 57 | 67 | PF02991 | 0.561 |
LIG_LIR_Gen_1 | 95 | 104 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 219 | 225 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 57 | 63 | PF02991 | 0.571 |
LIG_LIR_Nem_3 | 92 | 96 | PF02991 | 0.403 |
LIG_LYPXL_yS_3 | 203 | 206 | PF13949 | 0.505 |
LIG_MYND_1 | 204 | 208 | PF01753 | 0.422 |
LIG_Pex14_2 | 228 | 232 | PF04695 | 0.526 |
LIG_PTB_Apo_2 | 72 | 79 | PF02174 | 0.522 |
LIG_SH2_GRB2like | 216 | 219 | PF00017 | 0.445 |
LIG_SH2_NCK_1 | 35 | 39 | PF00017 | 0.586 |
LIG_SH2_SRC | 216 | 219 | PF00017 | 0.450 |
LIG_SH2_STAP1 | 35 | 39 | PF00017 | 0.547 |
LIG_SH2_STAT3 | 96 | 99 | PF00017 | 0.498 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 216 | 219 | PF00017 | 0.400 |
LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.409 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.577 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.490 |
LIG_SH3_3 | 98 | 104 | PF00018 | 0.456 |
LIG_SUMO_SIM_par_1 | 142 | 147 | PF11976 | 0.416 |
LIG_SUMO_SIM_par_1 | 175 | 182 | PF11976 | 0.556 |
LIG_SUMO_SIM_par_1 | 21 | 26 | PF11976 | 0.558 |
LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.533 |
LIG_TYR_ITIM | 201 | 206 | PF00017 | 0.514 |
LIG_UBA3_1 | 143 | 148 | PF00899 | 0.381 |
LIG_WW_3 | 1 | 5 | PF00397 | 0.718 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.544 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.545 |
MOD_CK2_1 | 154 | 160 | PF00069 | 0.588 |
MOD_CK2_1 | 173 | 179 | PF00069 | 0.420 |
MOD_CK2_1 | 221 | 227 | PF00069 | 0.391 |
MOD_CK2_1 | 52 | 58 | PF00069 | 0.399 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.635 |
MOD_Cter_Amidation | 48 | 51 | PF01082 | 0.402 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.608 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.537 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.538 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.402 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.438 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.501 |
MOD_N-GLC_2 | 231 | 233 | PF02516 | 0.534 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.507 |
MOD_NEK2_1 | 154 | 159 | PF00069 | 0.629 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.615 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.551 |
MOD_PIKK_1 | 164 | 170 | PF00454 | 0.590 |
MOD_PIKK_1 | 179 | 185 | PF00454 | 0.455 |
MOD_PIKK_1 | 78 | 84 | PF00454 | 0.592 |
MOD_PK_1 | 190 | 196 | PF00069 | 0.559 |
MOD_PKA_1 | 51 | 57 | PF00069 | 0.538 |
MOD_PKA_2 | 18 | 24 | PF00069 | 0.648 |
MOD_PKA_2 | 52 | 58 | PF00069 | 0.568 |
MOD_Plk_1 | 172 | 178 | PF00069 | 0.482 |
MOD_Plk_1 | 23 | 29 | PF00069 | 0.563 |
MOD_Plk_1 | 56 | 62 | PF00069 | 0.379 |
MOD_Plk_2-3 | 160 | 166 | PF00069 | 0.607 |
MOD_Plk_2-3 | 173 | 179 | PF00069 | 0.388 |
MOD_Plk_2-3 | 18 | 24 | PF00069 | 0.558 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.570 |
MOD_Plk_4 | 173 | 179 | PF00069 | 0.495 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.536 |
MOD_Plk_4 | 190 | 196 | PF00069 | 0.384 |
MOD_Plk_4 | 218 | 224 | PF00069 | 0.559 |
MOD_Plk_4 | 8 | 14 | PF00069 | 0.470 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.489 |
MOD_SUMO_for_1 | 208 | 211 | PF00179 | 0.485 |
MOD_SUMO_rev_2 | 113 | 118 | PF00179 | 0.500 |
MOD_SUMO_rev_2 | 61 | 69 | PF00179 | 0.571 |
TRG_ENDOCYTIC_2 | 203 | 206 | PF00928 | 0.505 |
TRG_ER_diArg_1 | 41 | 44 | PF00400 | 0.463 |
TRG_NLS_MonoCore_2 | 49 | 54 | PF00514 | 0.570 |
TRG_NLS_MonoExtN_4 | 50 | 55 | PF00514 | 0.566 |
TRG_Pf-PMV_PEXEL_1 | 127 | 132 | PF00026 | 0.528 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IHY5 | Leptomonas seymouri | 53% | 100% |
A0A0S4J677 | Bodo saltans | 22% | 77% |
A0A0S4JEV4 | Bodo saltans | 22% | 77% |
A0A1X0NX29 | Trypanosomatidae | 32% | 96% |
A0A3S7WYF1 | Leishmania donovani | 100% | 100% |
A4HDL2 | Leishmania braziliensis | 79% | 100% |
C9ZWH8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 96% |
E9AWX3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QAK1 | Leishmania major | 93% | 100% |
V5BAW4 | Trypanosoma cruzi | 32% | 81% |